College Football Fans Are Overjoyed With Jimbo Fisher’s Update About His Son, Ethan

Jimbo Fisher walks off the field with his son, Ethan, after a bowl game.

Getty Image

Jimbo Fisher gave fans an awesome update on his son, Ethan, who battles a rare genetic disease called Fanconi Anemia. He’s learned that he could possibly be cured through gene replacement therapy.

Ethan plans to begin that process in June, with a target date for his cure set at two to four years. College football followers have been quick to post their responses.

Fisher is prepping for Year 6 in College Station and he’s hoping for a better output than 2022. After entering the ’22 campaign as a top 10 team, the Aggies crumbled.

Texas A&M went 5-7, including a loss to App State, giving Fisher his first losing season as an SEC head coach.

As he looks to turn things around, he’s beginning to make the rounds on his offseason tour in hopes of exciting the fanbase following that subpar campaign.

While speaking in Dallas, Fisher overjoyed those fans with an update, though it had little to do with football.

Rather, it involved his son, who was diagnosed with Fanconi Anemia in 2011.

What is Fanconi Anemia?

According to MedlinePlus, Fanconi anemia is “a condition that affects many parts of the body. People with this condition may have bone marrow failure, physical abnormalities, organ defects, and an increased risk of certain cancers.”

It occurs in 1 in 160,000 individuals worldwide, and those with the rare blood disorder have an average lifespan of roughly 30 years.

Jimbo Fisher learned that his son could potentially be cured of the disease through gene replacement therapy.

The good news had everyone posting their reactions on social media.

One person wrote, “That is awesome news,” while another said, “Would love to see this happen.”

This follower commented, “Man, that would be awesome. Definitely praying for success.”

Fantastic news. Hoping for the best for Ethan.